Klinikum Leverkusen

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Heart failure2 trials
• Diffuse large B-cell lymphoma1 trial
• Obesity1 trial
• Ventricular tachycardia1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Amgen1 trial
• Biotronik SE & Co. KG1 trial
• Karyopharm Therapeutics Inc1 trial

Running trials

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Amgen· Source

• Active, not recruiting

  Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

  NCT02227251· Phase 2· Karyopharm Therapeutics Inc· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting
• Obesity1 recruiting

Closed trials

• Completed

  SD01 Registry (SD01 ICD Lead)

  NCT02014675· Biotronik SE & Co. KG· Source